<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01536717</url>
  </required_header>
  <id_info>
    <org_study_id>2011-004307-20</org_study_id>
    <nct_id>NCT01536717</nct_id>
  </id_info>
  <brief_title>Comparison of the Local Anaesthetics Articaine and Bupivacaine in Treatment of Acute Sternum Pain After Heart Surgery</brief_title>
  <official_title>Comparison of Periosteal and Subcutaneous Infusions of Articaine and Bupivacaine in Treatment of Acute Pain After Sternotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the wound infusion of articaine for treatment of
      acute post-sternotomy pain in a placebo-controlled manner using a prospective and randomized
      design and an active control (bupivacaine)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute pain after open heart surgery can be moderate or strong and is mostly caused by
      sternotomy. Pain is the worst during the first two post-operative days and, if not adequately
      treated, can delay the patient´s recovery from surgery. Sternotomy pain can be alleviated by
      using paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs) and opioids. All these
      drugs may have remarkable side-effects which may delay the recovery from surgery: opioids are
      respiratory depressants and slower the gastrointestinal motility, NSAIDs reduce intrarenal
      blood flow and may disturb coagulation. Post-operative opioid consumption can be reduced by
      using wound infiltration analgesia.

      The use of wound infiltration analgesia has not been extensively investigated in treatment of
      acute pain after sternotomy. There is some evidence, that 0.5% bupivacaine reduces the acute
      post-sternotomy pain when infused constantly via catheters placed under the fascia
      (periosteal placement) and the skin.

      During 48 hours infusion toxic bupivacaine plasma levels were not observed. There is an
      evidence that local anesthetics can be bacteriostatic both in vitro and in vivo.

      Articaine is an amide-type local anesthetics, which has been used extensively in dental
      procedures since more than forty years. It has been successfully used in infiltration,
      epidural, spinal and other regional anesthesia procedures. Articaine is quickly hydrolyzed in
      plasma and excreted by kidneys. Clearance of articain (500-1110l/h) is faster than that of
      lidocaine (68l/h) and it is also the reason for articaine´s low toxicity profile. Because of
      it´s low toxicity and high ability to penetrate the periosteal tissue, articaine may be
      advantageous in treatment of acute pain after sternotomy, but aforementioned indication for
      use of articaine has not been investigated. Compared to other local anesthetics, articaine in
      high concentration has the same neurotoxicity profile, when injected directly into rat´s
      sciatic nerve. Articaine has not been extensively compared to other local anesthetics, but
      according the latest odontologic investigation, single dose 0.5% bupivacaine and single-dose
      4% articaine were comparable in their analgesic effects during tooth extraction procedure.
      There are no controlled randomized trials comparing analgesic effect of articaine and other
      local anesthetics infusions.

      In our investigation bupivacain 0.5 % was chosen as an active control, because it has
      appeared effective in acute postoperative pain and it has reduced the need for opioid
      analgetics after sternotomy
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Withdrawal of principal investigator from clinical duties and organisational reasons
  </why_stopped>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxycodone consumption</measure>
    <time_frame>72 hours from initiation of treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intensity of pain in rest/in movement (AUC)</measure>
    <time_frame>72 hours from initiation of treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Diseases of Mitral Valve</condition>
  <condition>Aortic Valve Disorder</condition>
  <condition>Atrial Septal Defects</condition>
  <condition>Intracardiac Myxoma</condition>
  <arm_group>
    <arm_group_label>Bupivacaine hydrochloride 0.5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine hydrochloride is related chemically and pharmacologically to the aminoacyl local anesthetics. Bupivacaine hydrochloride is indicated for the production of local or regional anesthesia or analgesia for surgery, for oral surgery procedures, for diagnostic and therapeutic procedures, and for obstetrical procedures.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium chloride 0,9%</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Articaine hydrochloride 2% solution</intervention_name>
    <description>4 ml/h periosteal wound infusion
duration of 72 h</description>
    <arm_group_label>Bupivacaine hydrochloride 0.5%</arm_group_label>
    <other_name>Ultracain D ohne Adrenalin 20 mg/ml, ATC code N01BB08</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Chloride</intervention_name>
    <description>Placebo Sodium chloride 0,9%</description>
    <arm_group_label>Sodium chloride 0,9%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective procedure

          -  open heart surgery

          -  aortic valve surgery

          -  mitral valve surgery

          -  atrial septal defect repair surgery

          -  intracardial myxoma removal surgery

        Exclusion Criteria:

          -  local anesthetic allergy

          -  sulphide allergy

          -  asthma

          -  pregnant women

          -  neurological disease (TIA excluded)

          -  congestive heart failure

          -  left ventricle ejection fracture under 0.3

          -  liver failure

          -  diabetes mellitus with documented polyneuropathy

          -  chronic pain condition

          -  mother tongue not finnish or swedish

          -  patients, who do not agree blood transfusions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reino Pöyhiä, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anesthesiology and Intensive care, Division of Surgery, Meilahti Hospital, Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mihkel Meinberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology and Intensive care medicine, Division of Surgery, Meilahti Hospital, Helsinki University Central Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology and Intensive care medicine, Divison of Surgery, Meilahti hospital, Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <state>Uusimaa</state>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Cardiothoracic surgery, Division of Surgery, Meilahti hospital, Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <state>Uusimaa</state>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Kehlet H, Andersen LØ. Local infiltration analgesia in joint replacement: the evidence and recommendations for clinical practice. Acta Anaesthesiol Scand. 2011 Aug;55(7):778-84. doi: 10.1111/j.1399-6576.2011.02429.x. Epub 2011 Apr 4. Review.</citation>
    <PMID>21463261</PMID>
  </reference>
  <reference>
    <citation>White PF, Rawal S, Latham P, Markowitz S, Issioui T, Chi L, Dellaria S, Shi C, Morse L, Ing C. Use of a continuous local anesthetic infusion for pain management after median sternotomy. Anesthesiology. 2003 Oct;99(4):918-23.</citation>
    <PMID>14508326</PMID>
  </reference>
  <reference>
    <citation>Magnano D, Montalbano R, Lamarra M, Ferri F, Lorini L, Clarizia S, Rescigno G. Ineffectiveness of local wound anesthesia to reduce postoperative pain after median sternotomy. J Card Surg. 2005 Jul-Aug;20(4):314-8.</citation>
    <PMID>15985128</PMID>
  </reference>
  <reference>
    <citation>Pere P, Lindgren L, Vaara M. Poor antibacterial effect of ropivacaine: comparison with bupivacaine. Anesthesiology. 1999 Sep;91(3):884-6.</citation>
    <PMID>10485806</PMID>
  </reference>
  <reference>
    <citation>Vree TB, Gielen MJ. Clinical pharmacology and the use of articaine for local and regional anaesthesia. Best Pract Res Clin Anaesthesiol. 2005 Jun;19(2):293-308. Review.</citation>
    <PMID>15966499</PMID>
  </reference>
  <reference>
    <citation>Pelz K, Wiedmann-Al-Ahmad M, Bogdan C, Otten JE. Analysis of the antimicrobial activity of local anaesthetics used for dental analgesia. J Med Microbiol. 2008 Jan;57(Pt 1):88-94.</citation>
    <PMID>18065672</PMID>
  </reference>
  <reference>
    <citation>Vree TB, Baars AM, van Oss GE, Booij LH. High-performance liquid chromatography and preliminary pharmacokinetics of articaine and its 2-carboxy metabolite in human serum and urine. J Chromatogr. 1988 Feb 26;424(2):440-4.</citation>
    <PMID>3372637</PMID>
  </reference>
  <reference>
    <citation>Brinklov MM. Clinical effects of carticaine, a new local anesthetic. A survey and a double-blind investigation comparing carticaine with lidocaine in epidural analgesia. Acta Anaesthesiol Scand. 1977;21(1):5-16.</citation>
    <PMID>320810</PMID>
  </reference>
  <reference>
    <citation>Kallio H, Snäll EV, Luode T, Rosenberg PH. Hyperbaric articaine for day-case spinal anaesthesia. Br J Anaesth. 2006 Nov;97(5):704-9. Epub 2006 Aug 5.</citation>
    <PMID>16891634</PMID>
  </reference>
  <reference>
    <citation>Pitkänen MT, Xu M, Haasio J, Rosenberg PH. Comparison of 0.5% articaine and 0.5% prilocaine in intravenous regional anesthesia of the arm: a cross-over study in volunteers. Reg Anesth Pain Med. 1999 Mar-Apr;24(2):131-5.</citation>
    <PMID>10204898</PMID>
  </reference>
  <reference>
    <citation>Simon MA, Vree TB, Gielen MJ, Booij LH, Lagerwerf AJ. Similar motor block effects with different disposition kinetics between lidocaine and (+ or -) articaine in patients undergoing axillary brachial plexus block during day case surgery. Int J Clin Pharmacol Ther. 1999 Dec;37(12):598-607.</citation>
    <PMID>10599952</PMID>
  </reference>
  <reference>
    <citation>Trullenque-Eriksson A, Guisado-Moya B. Comparative study of two local anesthetics in the surgical extraction of mandibular third molars: bupivacaine and articaine. Med Oral Patol Oral Cir Bucal. 2011 May 1;16(3):e390-6.</citation>
    <PMID>21196829</PMID>
  </reference>
  <reference>
    <citation>Pesonen A, Suojaranta-Ylinen R, Hammarén E, Kontinen VK, Raivio P, Tarkkila P, Rosenberg PH. Pregabalin has an opioid-sparing effect in elderly patients after cardiac surgery: a randomized placebo-controlled trial. Br J Anaesth. 2011 Jun;106(6):873-81. doi: 10.1093/bja/aer083. Epub 2011 Apr 6.</citation>
    <PMID>21474474</PMID>
  </reference>
  <reference>
    <citation>Hillerup S, Bakke M, Larsen JO, Thomsen CE, Gerds TA. Concentration-dependent neurotoxicity of articaine: an electrophysiological and stereological study of the rat sciatic nerve. Anesth Analg. 2011 Jun;112(6):1330-8. doi: 10.1213/ANE.0b013e3182172a2e. Epub 2011 Apr 5.</citation>
    <PMID>21467556</PMID>
  </reference>
  <reference>
    <citation>Tirotta CF, Munro HM, Salvaggio J, Madril D, Felix DE, Rusinowski L, Tyler C, Decampli W, Hannan RL, Burke RP. Continuous incisional infusion of local anesthetic in pediatric patients following open heart surgery. Paediatr Anaesth. 2009 Jun;19(6):571-6. doi: 10.1111/j.1460-9592.2009.03009.x.</citation>
    <PMID>19645974</PMID>
  </reference>
  <reference>
    <citation>Hynninen MS, Cheng DC, Hossain I, Carroll J, Aumbhagavan SS, Yue R, Karski JM. Non-steroidal anti-inflammatory drugs in treatment of postoperative pain after cardiac surgery. Can J Anaesth. 2000 Dec;47(12):1182-7.</citation>
    <PMID>11132739</PMID>
  </reference>
  <reference>
    <citation>Lahtinen P, Kokki H, Hendolin H, Hakala T, Hynynen M. Propacetamol as adjunctive treatment for postoperative pain after cardiac surgery. Anesth Analg. 2002 Oct;95(4):813-9, table of contents.</citation>
    <PMID>12351250</PMID>
  </reference>
  <reference>
    <citation>Mueller XM, Tinguely F, Tevaearai HT, Revelly JP, Chioléro R, von Segesser LK. Pain location, distribution, and intensity after cardiac surgery. Chest. 2000 Aug;118(2):391-6.</citation>
    <PMID>10936130</PMID>
  </reference>
  <reference>
    <citation>Oertel R, Rahn R, Kirch W. Clinical pharmacokinetics of articaine. Clin Pharmacokinet. 1997 Dec;33(6):417-25. Review.</citation>
    <PMID>9435991</PMID>
  </reference>
  <reference>
    <citation>Simon MA, Vree TB, Gielen MJ, Booij LH. Comparison of the effects and disposition kinetics of articaine and lidocaine in 20 patients undergoing intravenous regional anaesthesia during day case surgery. Pharm World Sci. 1998 Apr;20(2):88-92.</citation>
    <PMID>9584343</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2012</study_first_submitted>
  <study_first_submitted_qc>February 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 22, 2012</study_first_posted>
  <last_update_submitted>October 29, 2017</last_update_submitted>
  <last_update_submitted_qc>October 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Reino Poyhia</investigator_full_name>
    <investigator_title>MD, PhD, Docent</investigator_title>
  </responsible_party>
  <keyword>atrial septal defect</keyword>
  <keyword>mitral valve annuloplasty</keyword>
  <keyword>aortic valve annuloplasty</keyword>
  <keyword>open heart surgery</keyword>
  <keyword>oxycodone consumption</keyword>
  <keyword>articain</keyword>
  <keyword>bupivacaine</keyword>
  <keyword>pain after sternotomy</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>wound infusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Septal Defects</mesh_term>
    <mesh_term>Heart Septal Defects, Atrial</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Carticaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

